NasdaqCM - Delayed Quote USD

Bon Natural Life Limited (BON)

2.7869 +0.0169 (+0.61%)
At close: May 13 at 4:00 PM EDT
2.6000 -0.19 (-6.71%)
After hours: May 13 at 5:39 PM EDT
Loading Chart for BON
DELL
  • Previous Close 2.7700
  • Open 2.9100
  • Bid --
  • Ask --
  • Day's Range 2.6700 - 2.9399
  • 52 Week Range 1.8900 - 8.0000
  • Volume 14,121
  • Avg. Volume 41,829
  • Market Cap (intraday) 3.885M
  • Beta (5Y Monthly) -1.10
  • PE Ratio (TTM) 0.56
  • EPS (TTM) 5.0000
  • Earnings Date Apr 30, 2024 - May 4, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 77.50

Bon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally. It offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. Its products are used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company was founded in 2006 and is based in Xi'an, the People's Republic of China.

www.bnlus.com

96

Full Time Employees

September 30

Fiscal Year Ends

Recent News: BON

Performance Overview: BON

Trailing total returns as of 5/13/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BON
48.39%
S&P 500
9.47%

1-Year Return

BON
51.11%
S&P 500
26.61%

3-Year Return

BON
--
S&P 500
22.38%

5-Year Return

BON
--
S&P 500
22.38%

Compare To: BON

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BON

Valuation Measures

Annual
As of 5/13/2024
  • Market Cap

    3.88M

  • Enterprise Value

    7.98M

  • Trailing P/E

    0.56

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.09

  • Price/Book (mrq)

    0.11

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.57%

  • Return on Assets (ttm)

    8.83%

  • Return on Equity (ttm)

    13.78%

  • Revenue (ttm)

    29.52M

  • Net Income Avi to Common (ttm)

    4.6M

  • Diluted EPS (ttm)

    5.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    112.82k

  • Total Debt/Equity (mrq)

    11.68%

  • Levered Free Cash Flow (ttm)

    -1.91M

Research Analysis: BON

Company Insights: BON

Research Reports: BON

People Also Watch